Abstract
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Journal of General Virology |
| Vol/bind | 84 |
| Udgave nummer | Pt 12 |
| Sider (fra-til) | 3429-41 |
| Antal sider | 12 |
| ISSN | 0022-1317 |
| Status | Udgivet - 2003 |
Bibliografisk note
Keywords: Animals; Base Sequence; Cell Line; DNA-Binding Proteins; Down-Regulation; Humans; Molecular Sequence Data; Oncogene Proteins, Viral; Open Reading Frames; Papillomaviridae; Promoter Regions, Genetic; Protein Binding; RNA, Messenger; RNA, Viral; Repressor Proteins; Transcription Factors; Transcriptional ActivationCitationsformater
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
I: Journal of General Virology, Bind 84, Nr. Pt 12, 2003, s. 3429-41.
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review
}
TY - JOUR
T1 - A promoter within the E6 ORF of human papillomavirus type 16 contributes to the expression of the E7 oncoprotein from a monocistronic mRNA
AU - Glahder, Jacob-Andreas Harald
AU - Hansen, Christina N
AU - Vinther, Jeppe
AU - Madsen, Birger S
AU - Norrild, Bodil
N1 - Keywords: Animals; Base Sequence; Cell Line; DNA-Binding Proteins; Down-Regulation; Humans; Molecular Sequence Data; Oncogene Proteins, Viral; Open Reading Frames; Papillomaviridae; Promoter Regions, Genetic; Protein Binding; RNA, Messenger; RNA, Viral; Repressor Proteins; Transcription Factors; Transcriptional Activation
PY - 2003
Y1 - 2003
N2 - Human papillomavirus type 16 (HPV-16) has the capacity to transform human primary keratinocytes. Maintenance of the transformed phenotype requires constitutive expression of the oncoproteins E6 and E7. The low-risk HPV types express E7 from monocistronic mRNA, but for the high-risk types, no mRNA that encodes E7 as the first open reading frame (ORF) has been identified. We recently identified a transcription initiation site within the E6 ORF of HPV-16 at nt 542. In the present study we have characterized the P542 promoter, which putatively controls monocistronic expression of E7. The monocistronic mRNA is not very abundant, but we have shown that an E7-luciferase fusion protein can be expressed in SiHa cells from a monocistronic HPV-16 transcript initiated at nt 542. The monocistronic mRNA expresses E7-luciferase more efficiently than the most abundant in vivo-like mRNA E6*IE7, initiated by P97 and spliced from nt 226 to 409. Furthermore, the translation initiation of E7 is most abundant from the monocistronic mRNA. We have also shown that the P542 promoter is downregulated by the transcription factor activator protein 4 (AP-4) and the differentiation-dependent factor hSkn-1a, both binding downstream of the transcription initiation site. In conclusion, we have found that P542 is a relatively weak promoter compared with P97 and may be downregulated in differentiated epithelial cells.
AB - Human papillomavirus type 16 (HPV-16) has the capacity to transform human primary keratinocytes. Maintenance of the transformed phenotype requires constitutive expression of the oncoproteins E6 and E7. The low-risk HPV types express E7 from monocistronic mRNA, but for the high-risk types, no mRNA that encodes E7 as the first open reading frame (ORF) has been identified. We recently identified a transcription initiation site within the E6 ORF of HPV-16 at nt 542. In the present study we have characterized the P542 promoter, which putatively controls monocistronic expression of E7. The monocistronic mRNA is not very abundant, but we have shown that an E7-luciferase fusion protein can be expressed in SiHa cells from a monocistronic HPV-16 transcript initiated at nt 542. The monocistronic mRNA expresses E7-luciferase more efficiently than the most abundant in vivo-like mRNA E6*IE7, initiated by P97 and spliced from nt 226 to 409. Furthermore, the translation initiation of E7 is most abundant from the monocistronic mRNA. We have also shown that the P542 promoter is downregulated by the transcription factor activator protein 4 (AP-4) and the differentiation-dependent factor hSkn-1a, both binding downstream of the transcription initiation site. In conclusion, we have found that P542 is a relatively weak promoter compared with P97 and may be downregulated in differentiated epithelial cells.
M3 - Journal article
C2 - 14645924
SN - 0022-1317
VL - 84
SP - 3429
EP - 3441
JO - Journal of General Virology
JF - Journal of General Virology
IS - Pt 12
ER -